<SEC-DOCUMENT>0001520023-23-000005.txt : 20230214
<SEC-HEADER>0001520023-23-000005.hdr.sgml : 20230214
<ACCEPTANCE-DATETIME>20230214115940
ACCESSION NUMBER:		0001520023-23-000005
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230214
DATE AS OF CHANGE:		20230214

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IDEXX LABORATORIES INC /DE
		CENTRAL INDEX KEY:			0000874716
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				010393723
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-41682
		FILM NUMBER:		23625159

	BUSINESS ADDRESS:	
		STREET 1:		ONE IDEXX DRIVE
		CITY:			WESTBROOK
		STATE:			ME
		ZIP:			04092-2041
		BUSINESS PHONE:		2075560300

	MAIL ADDRESS:	
		STREET 1:		ONE IDEXX DRIVE
		CITY:			WESTBROOK
		STATE:			ME
		ZIP:			04092-2041

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IDEXX CORP / DE
		DATE OF NAME CHANGE:	19600201

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Fundsmith LLP
		CENTRAL INDEX KEY:			0001569205
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			0313

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		33 CAVENDISH SQUARE
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1G 0PW
		BUSINESS PHONE:		44-020-3551-6339

	MAIL ADDRESS:	
		STREET 1:		33 CAVENDISH SQUARE
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1G 0PW
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>fundsmith_idexx2022.txt
<TEXT>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

SCHEDULE 13G
Under the Securities Exchange Act of 1934

Amendment No.:

Name of Issuer: IDEXX LABORATORIES INC

Title of Class of Securities:  Common Stock

CUSIP Number: 45168D104


  (Date of Event Which Requires Filing of this Statement)

                     December 31, 2022

Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:

/X/ Rule 13d-l(b)
/ / Rule 13d-l(c)
/ / Rule 13d-l(d)


*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect
to the subject class of securities, and for any subsequent
amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of
Section 18 of the Securities Exchange Act of 1934 ("Act") or
otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act
(however, see the Notes).




<PAGE>

CUSIP Number: 45168D104

1.  Name of Reporting Person
    Fundsmith LLP

2.  Check the Appropriate Box if a Member of a Group
         a. /X/
         b. / /

3.  SEC Use Only

4.  Citizenship or Place of Organization
         United Kingdom

Number of Shares Beneficially Owned by Each Reporting Person
With:

5.  Sole Voting Power:
         4,433,683

6.  Shared Voting Power:
         NONE

7.  Sole Dispositive Power:
         4,447,828

8.  Shared Dispositive Power:
         NONE

9.  Aggregate Amount Beneficially Owned by Each Reporting
Person
         4,447,828

10. Check Box if the Aggregate Amount in Row (9) Excludes
    Certain Shares  / /

11. Percent of Class Represented by Amount in Row (9)
         5.37%

12. Type of Reporting Person
         IA










                            -2-



<PAGE>

Item 1(a) Name of Issuer:
          IDEXX LABORATORIES INC

      (b) Address of Issuer's Principal Executive Offices:
          One IDEXX Drive, Westbrook, ME 04092, United States

Item 2(a) - (c).  Name, Principal Business Address, and
Citizenship of Persons Filing:

         Fundsmith LLP
         33 Cavendish Square, London, UK, W1G 0PQ

    (d)  Title of Class of Securities:  Common Stock

    (e)  CUSIP Number: 45168D104

Item 3.  This statement is filed pursuant to Rule
13d-1(b)(1).

    /x/  Group, in accordance with Rule 13d-1(b)(1) (ii)(J)

 Item 4. Ownership.
         (a) Amount Beneficially Owned:            4,447,828
         (b) Percent of Class:                     5.37%
         (c)  (i) shares with sole power to vote or direct
              the vote:                            4,433,683
              (ii) shared power to vote or direct the vote:
                                                   NONE
              (iii) shares with sole power to dispose or to
              direct the disposition of:           4,447,828
              (iv) shares with shared power to dispose or
              direct the disposition of:           NONE

Item 5.  Ownership of Five Percent or Less of a Class.

         If this statement is being filed to report the fact
that as of the date hereof the reporting person has ceased
to be the beneficial owner of more than 5 percent of the
class of securities, check the following /x/.

Item 6.  Ownership of More than Five Percent on Behalf of
Another Person.

         N/A

                            -3-


<PAGE>


Item 7.  Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported by the Parent
Holding Company.

         N/A

Item 8.  Identification and Classification of Members of the
Group.

         See Exhibit 1

Item 9.  Notice of Dissolution of the Group.

         N/A

Item 10. Certification
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and are held
in the ordinary course of business and were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having that purpose or effect.

After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true,
complete and correct.




By: /s/ Simon Godwin                         February 14, 2023
   _________________________                _________________
   Title: Chief Financial Officer	    Date
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>2
<FILENAME>EX-1.txt
<TEXT>
Exhibit 1

--------

Item 8

Fundsmith LLP is a Securities Affiliate of Fundsmith Investment
Services Ltd, an Investment Manager incorporated in Mauritius.
Fundsmith Investment Services Limited is 8.34% owned by Mr Mark
Laurence, 13.83% by Mr Julian Robins and 77.83% by Eighth Wonder
Limited which is 100% owned by THE EIGHTH WONDER FOUNDATION.
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
